Sprouty4 interferes with cell proliferation and migration of breast cancer-derived cell lines

Sprouty proteins are modulators of mitogen-induced signal transduction processes and therefore can influence the process of cancerogenesis. In particular, Sprouty2 has been shown to have an important role in cancer development of many tumor entities including breast cancer. In this report, we investigated the role of Sprouty4 in breast cancer-derived cell lines. We have found that ectopic Sprouty4 expression inhibits cell proliferation of breast cancer cell lines independently of their endogenous expression levels. Corroborating Sprouty4 downregulation causes accelerated growth. Furthermore, we demonstrate that an increase in Sprouty4 content interferes with serum-induced activation of mitogen-activated protein kinase pathway. Additionally, Sprouty4 expression negatively influences cell migration. These data suggest that Sprouty4 is a possible candidate for a tumor suppressor in breast cancer.

[1]  Joel P. Christensen,et al.  Homeric Space , 2012, The Classical Review.

[2]  N. Hacohen,et al.  Vertebrate Sprouty genes are induced by FGF signaling and can cause chondrodysplasia when overexpressed. , 1999, Development.

[3]  J. Licht,et al.  Sprouty Proteins Inhibit Receptor-mediated Activation of Phosphatidylinositol-specific Phospholipase C , 2010, Molecular biology of the cell.

[4]  V. Litvak,et al.  Sprouty Fine-Tunes EGF Signaling through Interlinked Positive and Negative Feedback Loops , 2003, Current Biology.

[5]  J. Squire,et al.  The Genetics of Osteosarcoma , 2012, Sarcoma.

[6]  A. Yoshimura,et al.  Loss of mammalian Sprouty2 leads to enteric neuronal hyperplasia and esophageal achalasia , 2005, Nature Neuroscience.

[7]  K. Ohashi,et al.  Sprouty-4 negatively regulates cell spreading by inhibiting the kinase activity of testicular protein kinase. , 2005, The Biochemical journal.

[8]  Raphael A Nemenoff,et al.  Sprouty-4 Inhibits Transformed Cell Growth, Migration and Invasion, and Epithelial-Mesenchymal Transition, and Is Regulated by Wnt7A through PPARγ in Non–Small Cell Lung Cancer , 2010, Molecular Cancer Research.

[9]  Jane Fridlyand,et al.  Integration of genomic analysis and in vivo transfection to identify sprouty 2 as a candidate tumor suppressor in liver cancer , 2007, Hepatology.

[10]  J. Thiery,et al.  Cloning and expression pattern of a mouse homologue of Drosophila sprouty in the mouse embryo , 1999, Mechanisms of Development.

[11]  G. Christofori,et al.  Modulation of Endocrine Pancreas Development but not β-Cell Carcinogenesis by Sprouty4 , 2008, Molecular Cancer Research.

[12]  W. Berger,et al.  Down-Regulation of Sprouty2 in Non–Small Cell Lung Cancer Contributes to Tumor Malignancy via Extracellular Signal-Regulated Kinase Pathway-Dependent and -Independent Mechanisms , 2007, Molecular Cancer Research.

[13]  J. Hernandez,et al.  SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity , 2010, Oncogene.

[14]  Matthew Freeman,et al.  Sprouty, an Intracellular Inhibitor of Ras Signaling , 1999, Cell.

[15]  T. Patel,et al.  Intermolecular Interactions of Sprouty Proteins and Their Implications in Development and Disease , 2009, Molecular Pharmacology.

[16]  M. Bissonnette,et al.  Sprouty-2 Controls c-Met Expression and Metastatic Potential of Colon Cancer Cells: Sprouty/c-Met Upregulation in Human Colonic Adenocarcinomas , 2010, Oncogene.

[17]  J. Licht,et al.  Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling. , 2006, Trends in cell biology.

[18]  S. So,et al.  Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma. , 2006, Cancer research.

[19]  S. Baker,et al.  The Tumor Suppressor PTEN Is Necessary for Human Sprouty 2-mediated Inhibition of Cell Proliferation* , 2006, Journal of Biological Chemistry.

[20]  Jonathan W. Pillow,et al.  POSTER PRESENTATION Open Access , 2013 .

[21]  T. Putti,et al.  The Ras/Mitogen-Activated Protein Kinase Pathway Inhibitor and Likely Tumor Suppressor Proteins, Sprouty 1 and Sprouty 2 Are Deregulated in Breast Cancer , 2004, Cancer Research.

[22]  A. Yoshimura,et al.  Mammalian Sprouty4 Suppresses Ras-Independent ERK Activation by Binding to Raf1 , 2003, Cell cycle.

[23]  W. Berger,et al.  Bimodal expression of Sprouty2 during the cell cycle is mediated by phase-specific Ras/MAPK and c-Cbl activities , 2010, Cellular and Molecular Life Sciences.

[24]  Z. Hall.  Cancer , 1906, The Hospital.

[25]  E. Choi,et al.  Pathological roles of MAPK signaling pathways in human diseases. , 2010, Biochimica et biophysica acta.

[26]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[27]  G. Guy,et al.  Sprouty2 Inhibits the Ras/MAP Kinase Pathway by Inhibiting the Activation of Raf* , 2002, The Journal of Biological Chemistry.

[28]  A. McMahon,et al.  Sprouty1 is a critical regulator of GDNF/RET-mediated kidney induction. , 2005, Developmental cell.

[29]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[30]  A. Sivachenko,et al.  Sequence analysis of mutations and translocations across breast cancer subtypes , 2012, Nature.

[31]  A. Gsur,et al.  In non‐small cell lung cancer mitogenic signaling leaves Sprouty1 protein levels unaffected , 2014, Cell biochemistry and function.

[32]  Michael Ittmann,et al.  Sprouty4, a suppressor of tumor cell motility, is downregulated by DNA methylation in human prostate cancer , 2006, The Prostate.

[33]  Y. Maehara,et al.  Sprouty2 and Sprouty4 are essential for embryonic morphogenesis and regulation of FGF signaling. , 2007, Biochemical and biophysical research communications.

[34]  A. Gsur,et al.  Sprouty2 but not Sprouty4 is a potent inhibitor of cell proliferation and migration of osteosarcoma cells , 2013, FEBS letters.

[35]  D. Harrison,et al.  Sprouty 2 Is an Independent Prognostic Factor in Breast Cancer and May Be Useful in Stratifying Patients for Trastuzumab Therapy , 2011, PloS one.

[36]  Patricia D. Castro,et al.  The Expression of Sprouty1, an Inhibitor of Fibroblast Growth Factor Signal Transduction, Is Decreased in Human Prostate Cancer , 2004, Cancer Research.